Sinovac Biotech’s vaccine against COVID-19 is over 50% effective in late-stage trials, newspaper Folha de S. Paulo reported.
Reuters Health Information
Archives
Tennessee emerged as an epicenter of the latest COVID-19 surge as US political leaders sought to guard against a highly contagious variant sweeping across Britain.
Reuters Health Information
Cabotegravir plus rilpivirine given by injection every 8 weeks appeared to be a promising new therapeutic option for people living with HIV at the 48-week mark in the ATLAS-2M trial.
Reuters Health Information
The first study to investigate seizure risk in pregnancy with the inclusion of a control group has provided reassuring results.
Medscape Medical News
Detecting apathy could help identify patients before they develop the condition and give a window of opportunity for preventive interventions, a new study suggests.
Medscape Medical News
California’s overwhelmed hospitals are setting up makeshift extra beds for COVID-19 patients and are drawing up emergency plans in case they have to limit how many people receive lifesaving care.
Associated Press
The CDC’s ACIP panel identified key groups who will be in the next two vaccination waves, including those aged 75 years and older, some essential workers, and those with high-risk medical conditions.
Medscape Medical News
Army Gen. Gustave Perna says he alone was responsible for miscalculating the numbers of ‘releasable’ doses, which left states short. He emphasized there is no problem with the process or the vaccines.
Medscape Medical News
The most ambitious vaccine advancement in history is well underway. Scientists, however, say they have the capability to shave months off this timeline to save lives in pandemic times.
Medscape Medical News
Although preferring one-on-one visits, individuals receiving outpatient treatment for opioid use disorder in a new study reported a high degree of satisfaction with shared medical appointments.
Medscape Medical News